BMS-833923 (XL-139)

BMS-833923, also known as XL-139, is an orally bioavailable small molecule SMO (smooth) inhibitor with potential anti-tumor activity. The SMO antagonist BMS-833923 inhibits the sonic hedgehog (SHH) pathway protein SMO, which may lead to inhibition of the SHH signaling pathway.
Supplier Alfa Cytology
Product # BC0357
Pricing 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback